Quantitative mRNA Expression Assays and Synchronous Breast Cancers: A Case Report

Quantitative mRNA Expression Assays and Synchronous Breast Cancers: A Case Report

Quantitative mRNA analysis of breast tumors represents a routinely applied example of precision oncology. Currently the National Comprehensive Cancer Network (NCCN) recommends quantitative mRNA profiling (e.g., 21-gene RT PCR or Oncotype Dx assay) for nearly all surgically resected lymph node (LN) n...

Full description

Bibliographic Details
Main Author: Steven Sorscher
Format: Article
Language:English
Published: Karger Publishers 2019-06-01
Series:Case Reports in Oncology
Subjects:
Synchronous
Risk assessment
Quantitative RNA
Online Access:https://www.karger.com/Article/FullText/500670

Similar Items

Similar Items